Eur Rev Med Pharmacol Sci 2018; 22 (21): 7183-7188

DOI: 10.26355/eurrev_201811_16251

Long non-coding RNA PVT1 functions as an oncogene in ovarian cancer via upregulating SOX2

M.-F. Zou, J. Ling, Q.-Y. Wu, C.-X. Zhang

Department of Obstetrics and Gynecology, Wujin Hospital of Traditional Chinese Medicine Affiliated to Nanjing University of Chinese Medicine, Changzhou, China. lingjing_112@163.com


OBJECTIVE: The aim of this study was to identify the role of long non-coding RNA PVT1 (lnc-PVT1) in the progression of ovarian cancer.

PATIENTS AND METHODS: The expression of lnc-PVT1 in ovarian cancer cells and 50 paired tissue samples were detected by quantitative Reverse Transcriptase-Polymerase Chain Reaction (qRT-PCR). Moreover, cell proliferation assay and transwell assay were performed to identify the function of lnc-PVT1 in vitro. QRT-PCR and Western blot were utilized to explore the possible underlying mechanism.

RESULTS: Compared with normal tissues, the expression of lnc-PVT1 T1 was remarkably upregulated in tumor tissues. Moreover, the proliferation and invasion of ovarian cancer were promoted after knockdown of lnc-PVT1 in vitro. Moreover, both the mRNA and protein levels of SOX2 were suppressed after knockdown of lnc-PVT1 in vitro. Besides, the expression of SOX2 in tumor tissues was positively correlated to lnc-PVT1.

CONCLUSIONS: Lnc-PVT1 could enhance the invasion and proliferation of ovarian cancer cells through upregulating SOX2, which might serve as a new therapeutic target for the treatment of ovarian cancer.

Free PDF Download

To cite this article

M.-F. Zou, J. Ling, Q.-Y. Wu, C.-X. Zhang
Long non-coding RNA PVT1 functions as an oncogene in ovarian cancer via upregulating SOX2

Eur Rev Med Pharmacol Sci
Year: 2018
Vol. 22 - N. 21
Pages: 7183-7188
DOI: 10.26355/eurrev_201811_16251